Augmenter of Liver Regeneration (ALR) Protects Kidney from Ischemia/Reperfusion (I/R) Injury via Regulation of TLR4/MAPK Signaling Pathway

Toll-like receptor 4 (TLR4) can mediate innate activation and inflammation, and it is typically expressed within the ischemic kidney. Augmenter of liver regeneration (ALR) acts as an immunoregulator with a high expression in the kidney induced by renal ischemia/reperfusion (I/R) injury. Exogenous AL...

Full description

Saved in:
Bibliographic Details
Main Authors: Ying Li, Yanying Xiong, Huihui Li, Yan Luo, Ling Zhang, Qin Zhang, Weijian Xiong, Haitao Tu
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2022/6869730
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561883036516352
author Ying Li
Yanying Xiong
Huihui Li
Yan Luo
Ling Zhang
Qin Zhang
Weijian Xiong
Haitao Tu
author_facet Ying Li
Yanying Xiong
Huihui Li
Yan Luo
Ling Zhang
Qin Zhang
Weijian Xiong
Haitao Tu
author_sort Ying Li
collection DOAJ
description Toll-like receptor 4 (TLR4) can mediate innate activation and inflammation, and it is typically expressed within the ischemic kidney. Augmenter of liver regeneration (ALR) acts as an immunoregulator with a high expression in the kidney induced by renal ischemia/reperfusion (I/R) injury. Exogenous ALR has indicated a role in protecting the kidney from I/R injury. The protective effect of ALR is due to the immune regulatory function which remains to be elucidated. In this study, rats induced by renal I/R were treated with recombinant human ALR (rhALR) and demonstrated that the animals were protected from kidney I/R injury, implying that the rhALR-treated rats had less tubular damage than those untreated rats. Meanwhile, tubular epithelial cell apoptosis, neutrophil (24 h) and macrophage (72 h) infiltration to tubulointerstitium, and levels of inflammatory cytokines were decreased considerably in the rhALR-treated rats as compared to control. Additionally, rhALR could downregulate mRNA expression of TLR4 endogenous ligands and restrain its activation in renal I/R injury rats. It has also been proved that anti-rhALR antibody blocked the inhibition of rhALR of the immune inflammatory response in hypoxia/reoxygenation (H/R) injury in vitro. In rhALR+anti-rhALR antibody-intervened H/R cells, the expression of inflammatory cytokines was upregulated compared with the rhALR-treated cells. Taken together, rhALR could regulate the TLR4 signaling pathway to relieve inflammatory response, thereby protecting renal I/R injury, indicating that ALR is likely to be introduced to develop novel immune therapies for renal I/R injury.
format Article
id doaj-art-f9a06ae0421e4f72975e815f45c6bafd
institution Kabale University
issn 2314-7156
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-f9a06ae0421e4f72975e815f45c6bafd2025-02-03T01:24:09ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/6869730Augmenter of Liver Regeneration (ALR) Protects Kidney from Ischemia/Reperfusion (I/R) Injury via Regulation of TLR4/MAPK Signaling PathwayYing Li0Yanying Xiong1Huihui Li2Yan Luo3Ling Zhang4Qin Zhang5Weijian Xiong6Haitao Tu7Department of NephrologyDepartment of NephrologyDepartment of NephrologyDepartment of NephrologyDepartment of NephrologyDepartment of NephrologyDepartment of NephrologyDepartment of NephrologyToll-like receptor 4 (TLR4) can mediate innate activation and inflammation, and it is typically expressed within the ischemic kidney. Augmenter of liver regeneration (ALR) acts as an immunoregulator with a high expression in the kidney induced by renal ischemia/reperfusion (I/R) injury. Exogenous ALR has indicated a role in protecting the kidney from I/R injury. The protective effect of ALR is due to the immune regulatory function which remains to be elucidated. In this study, rats induced by renal I/R were treated with recombinant human ALR (rhALR) and demonstrated that the animals were protected from kidney I/R injury, implying that the rhALR-treated rats had less tubular damage than those untreated rats. Meanwhile, tubular epithelial cell apoptosis, neutrophil (24 h) and macrophage (72 h) infiltration to tubulointerstitium, and levels of inflammatory cytokines were decreased considerably in the rhALR-treated rats as compared to control. Additionally, rhALR could downregulate mRNA expression of TLR4 endogenous ligands and restrain its activation in renal I/R injury rats. It has also been proved that anti-rhALR antibody blocked the inhibition of rhALR of the immune inflammatory response in hypoxia/reoxygenation (H/R) injury in vitro. In rhALR+anti-rhALR antibody-intervened H/R cells, the expression of inflammatory cytokines was upregulated compared with the rhALR-treated cells. Taken together, rhALR could regulate the TLR4 signaling pathway to relieve inflammatory response, thereby protecting renal I/R injury, indicating that ALR is likely to be introduced to develop novel immune therapies for renal I/R injury.http://dx.doi.org/10.1155/2022/6869730
spellingShingle Ying Li
Yanying Xiong
Huihui Li
Yan Luo
Ling Zhang
Qin Zhang
Weijian Xiong
Haitao Tu
Augmenter of Liver Regeneration (ALR) Protects Kidney from Ischemia/Reperfusion (I/R) Injury via Regulation of TLR4/MAPK Signaling Pathway
Journal of Immunology Research
title Augmenter of Liver Regeneration (ALR) Protects Kidney from Ischemia/Reperfusion (I/R) Injury via Regulation of TLR4/MAPK Signaling Pathway
title_full Augmenter of Liver Regeneration (ALR) Protects Kidney from Ischemia/Reperfusion (I/R) Injury via Regulation of TLR4/MAPK Signaling Pathway
title_fullStr Augmenter of Liver Regeneration (ALR) Protects Kidney from Ischemia/Reperfusion (I/R) Injury via Regulation of TLR4/MAPK Signaling Pathway
title_full_unstemmed Augmenter of Liver Regeneration (ALR) Protects Kidney from Ischemia/Reperfusion (I/R) Injury via Regulation of TLR4/MAPK Signaling Pathway
title_short Augmenter of Liver Regeneration (ALR) Protects Kidney from Ischemia/Reperfusion (I/R) Injury via Regulation of TLR4/MAPK Signaling Pathway
title_sort augmenter of liver regeneration alr protects kidney from ischemia reperfusion i r injury via regulation of tlr4 mapk signaling pathway
url http://dx.doi.org/10.1155/2022/6869730
work_keys_str_mv AT yingli augmenterofliverregenerationalrprotectskidneyfromischemiareperfusionirinjuryviaregulationoftlr4mapksignalingpathway
AT yanyingxiong augmenterofliverregenerationalrprotectskidneyfromischemiareperfusionirinjuryviaregulationoftlr4mapksignalingpathway
AT huihuili augmenterofliverregenerationalrprotectskidneyfromischemiareperfusionirinjuryviaregulationoftlr4mapksignalingpathway
AT yanluo augmenterofliverregenerationalrprotectskidneyfromischemiareperfusionirinjuryviaregulationoftlr4mapksignalingpathway
AT lingzhang augmenterofliverregenerationalrprotectskidneyfromischemiareperfusionirinjuryviaregulationoftlr4mapksignalingpathway
AT qinzhang augmenterofliverregenerationalrprotectskidneyfromischemiareperfusionirinjuryviaregulationoftlr4mapksignalingpathway
AT weijianxiong augmenterofliverregenerationalrprotectskidneyfromischemiareperfusionirinjuryviaregulationoftlr4mapksignalingpathway
AT haitaotu augmenterofliverregenerationalrprotectskidneyfromischemiareperfusionirinjuryviaregulationoftlr4mapksignalingpathway